Global Circulating Tumor Cell Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Circulating Tumor Cell Revenue
• 1.4 Market by Type
  • 1.4.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CTC Enrichment
  • 1.4.3 CTC Detection
  • 1.4.4 CTC Analysis
• 1.5 Market by Application
  • 1.5.1 Global Circulating Tumor Cell Market Share by Application: 2020 VS 2026
  • 1.5.2 Breast Cancer
  • 1.5.3 Prostate Cancer
  • 1.5.4 Colorectal Cancer
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Circulating Tumor Cell Market Perspective (2015-2026)
• 2.2 Global Circulating Tumor Cell Growth Trends by Regions
  • 2.2.1 Circulating Tumor Cell Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Circulating Tumor Cell Historic Market Share by Regions (2015-2020)
  • 2.2.3 Circulating Tumor Cell Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Circulating Tumor Cell Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Circulating Tumor Cell Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Circulating Tumor Cell Players by Market Size
  • 3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2015-2020)
  • 3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Circulating Tumor Cell Market Concentration Ratio
  • 3.2.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2019
• 3.3 Circulating Tumor Cell Key Players Head office and Area Served
• 3.4 Key Players Circulating Tumor Cell Product Solution and Service
• 3.5 Date of Enter into Circulating Tumor Cell Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Circulating Tumor Cell Historic Market Size by Type (2015-2020)
• 4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Circulating Tumor Cell Market Size by Application (2015-2020)
• 5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Circulating Tumor Cell Market Size (2015-2020)
• 6.2 Circulating Tumor Cell Key Players in North America (2019-2020)
• 6.3 North America Circulating Tumor Cell Market Size by Type (2015-2020)
• 6.4 North America Circulating Tumor Cell Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Circulating Tumor Cell Market Size (2015-2020)
• 7.2 Circulating Tumor Cell Key Players in Europe (2019-2020)
• 7.3 Europe Circulating Tumor Cell Market Size by Type (2015-2020)
• 7.4 Europe Circulating Tumor Cell Market Size by Application (2015-2020)

8 China

• 8.1 China Circulating Tumor Cell Market Size (2015-2020)
• 8.2 Circulating Tumor Cell Key Players in China (2019-2020)
• 8.3 China Circulating Tumor Cell Market Size by Type (2015-2020)
• 8.4 China Circulating Tumor Cell Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Circulating Tumor Cell Market Size (2015-2020)
• 9.2 Circulating Tumor Cell Key Players in Japan (2019-2020)
• 9.3 Japan Circulating Tumor Cell Market Size by Type (2015-2020)
• 9.4 Japan Circulating Tumor Cell Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Circulating Tumor Cell Market Size (2015-2020)
• 10.2 Circulating Tumor Cell Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Circulating Tumor Cell Market Size by Type (2015-2020)
• 10.4 Southeast Asia Circulating Tumor Cell Market Size by Application (2015-2020)

11 India

• 11.1 India Circulating Tumor Cell Market Size (2015-2020)
• 11.2 Circulating Tumor Cell Key Players in India (2019-2020)
• 11.3 India Circulating Tumor Cell Market Size by Type (2015-2020)
• 11.4 India Circulating Tumor Cell Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Circulating Tumor Cell Market Size (2015-2020)
• 12.2 Circulating Tumor Cell Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Circulating Tumor Cell Market Size by Type (2015-2020)
• 12.4 Central & South America Circulating Tumor Cell Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Menarini-Silicon Biosystems
  • 13.1.1 Menarini-Silicon Biosystems Company Details
  • 13.1.2 Menarini-Silicon Biosystems Business Overview
  • 13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction
  • 13.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2015-2020))
  • 13.1.5 Menarini-Silicon Biosystems Recent Development
• 13.2 Qiagen（Adnagen）
  • 13.2.1 Qiagen（Adnagen） Company Details
  • 13.2.2 Qiagen（Adnagen） Business Overview
  • 13.2.3 Qiagen（Adnagen） Circulating Tumor Cell Introduction
  • 13.2.4 Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.2.5 Qiagen（Adnagen） Recent Development
• 13.3 Clearbridge Biomedics
  • 13.3.1 Clearbridge Biomedics Company Details
  • 13.3.2 Clearbridge Biomedics Business Overview
  • 13.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction
  • 13.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.3.5 Clearbridge Biomedics Recent Development
• 13.4 Celsee
  • 13.4.1 Celsee Company Details
  • 13.4.2 Celsee Business Overview
  • 13.4.3 Celsee Circulating Tumor Cell Introduction
  • 13.4.4 Celsee Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.4.5 Celsee Recent Development
• 13.5 Fluidigm
  • 13.5.1 Fluidigm Company Details
  • 13.5.2 Fluidigm Business Overview
  • 13.5.3 Fluidigm Circulating Tumor Cell Introduction
  • 13.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.5.5 Fluidigm Recent Development
• 13.6 ApoCell
  • 13.6.1 ApoCell Company Details
  • 13.6.2 ApoCell Business Overview
  • 13.6.3 ApoCell Circulating Tumor Cell Introduction
  • 13.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.6.5 ApoCell Recent Development
• 13.7 Greiner Bio-one GmbH
  • 13.7.1 Greiner Bio-one GmbH Company Details
  • 13.7.2 Greiner Bio-one GmbH Business Overview
  • 13.7.3 Greiner Bio-one GmbH Circulating Tumor Cell Introduction
  • 13.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.7.5 Greiner Bio-one GmbH Recent Development
• 13.8 Advanced Cell Diagnostics
  • 13.8.1 Advanced Cell Diagnostics Company Details
  • 13.8.2 Advanced Cell Diagnostics Business Overview
  • 13.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction
  • 13.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.8.5 Advanced Cell Diagnostics Recent Development
• 13.9 Aviva Biosciences
  • 13.9.1 Aviva Biosciences Company Details
  • 13.9.2 Aviva Biosciences Business Overview
  • 13.9.3 Aviva Biosciences Circulating Tumor Cell Introduction
  • 13.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.9.5 Aviva Biosciences Recent Development
• 13.10 Fluxion Biosciences
  • 13.10.1 Fluxion Biosciences Company Details
  • 13.10.2 Fluxion Biosciences Business Overview
  • 13.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction
  • 13.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
  • 13.10.5 Fluxion Biosciences Recent Development
• 13.11 Sysmex Corporation
  • 10.11.1 Sysmex Corporation Company Details
  • 10.11.2 Sysmex Corporation Business Overview
  • 10.11.3 Sysmex Corporation Circulating Tumor Cell Introduction
  • 10.11.4 Sysmex Corporation Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.11.5 Sysmex Corporation Recent Development
• 13.12 Epic Sciences
  • 10.12.1 Epic Sciences Company Details
  • 10.12.2 Epic Sciences Business Overview
  • 10.12.3 Epic Sciences Circulating Tumor Cell Introduction
  • 10.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.12.5 Epic Sciences Recent Development
• 13.13 Cynvenio
  • 10.13.1 Cynvenio Company Details
  • 10.13.2 Cynvenio Business Overview
  • 10.13.3 Cynvenio Circulating Tumor Cell Introduction
  • 10.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.13.5 Cynvenio Recent Development
• 13.14 CytoTrack
  • 10.14.1 CytoTrack Company Details
  • 10.14.2 CytoTrack Business Overview
  • 10.14.3 CytoTrack Circulating Tumor Cell Introduction
  • 10.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.14.5 CytoTrack Recent Development
• 13.15 Ikonisys
  • 10.15.1 Ikonisys Company Details
  • 10.15.2 Ikonisys Business Overview
  • 10.15.3 Ikonisys Circulating Tumor Cell Introduction
  • 10.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.15.5 Ikonisys Recent Development
• 13.16 Vortex BioSciences
  • 10.16.1 Vortex BioSciences Company Details
  • 10.16.2 Vortex BioSciences Business Overview
  • 10.16.3 Vortex BioSciences Circulating Tumor Cell Introduction
  • 10.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.16.5 Vortex BioSciences Recent Development
• 13.17 Gilupi
  • 10.17.1 Gilupi Company Details
  • 10.17.2 Gilupi Business Overview
  • 10.17.3 Gilupi Circulating Tumor Cell Introduction
  • 10.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.17.5 Gilupi Recent Development
• 13.18 Biocept
  • 10.18.1 Biocept Company Details
  • 10.18.2 Biocept Business Overview
  • 10.18.3 Biocept Circulating Tumor Cell Introduction
  • 10.18.4 Biocept Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.18.5 Biocept Recent Development
• 13.19 ScreenCell
  • 10.19.1 ScreenCell Company Details
  • 10.19.2 ScreenCell Business Overview
  • 10.19.3 ScreenCell Circulating Tumor Cell Introduction
  • 10.19.4 ScreenCell Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.19.5 ScreenCell Recent Development
• 13.20 ANGLE
  • 10.20.1 ANGLE Company Details
  • 10.20.2 ANGLE Business Overview
  • 10.20.3 ANGLE Circulating Tumor Cell Introduction
  • 10.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2015-2020)
  • 10.20.5 ANGLE Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer